Sharon J.  Larson net worth and biography

Sharon Larson Biography and Net Worth

Director of Heska
Sharon J. Larson has served us as a Director since July 2011 and as our Board Chair from October 2015 to the October 2018. Ms. Larson was also our Lead Director from May 2014 to October 2015. Ms. Larson currently serves as Principal and CEO of SLR Associates, LLC, a healthcare consulting firm. Ms. Larson served as Chief Executive Officer UT Southwestern University Hospitals and Vice President for University Hospitals, UT Southwestern Medical Center from 2004 to 2010. From 2000 to 2004 she was the COO at Anne Arundel Health System in Annapolis, Maryland. She held various jobs (Associate Administrator, COO and Corporate Vice President) during her employment in the Nebraska Health System from 1995 to 2000. From 1990 to 1995 she was an Assistant Administrator in the Inova Health System in Virginia. Prior to 1990 she was with Brackenridge Hospital in Austin, Texas and the Good Samaritan Hospital and Health Center in Dayton, Ohio. Ms. Larson currently serves as an Advisor to DigiWorksCorp, and as a member of the Innovation Council of Anthello Healthcare Solutions, Inc. She has also served on various boards and been involved with several community projects. Ms. Larson holds BBA (Business Administration) and MA (Hospital and Health Administration) degrees from the University of Iowa. Ms. Larson’s executive experience in the healthcare industry and management positions with major healthcare companies provide an excellent background for service on the Board.

What is Sharon J. Larson's net worth?

The estimated net worth of Sharon J. Larson is at least $1.14 million as of August 17th, 2021. Ms. Larson owns 9,501 shares of Heska stock worth more than $1,140,025 as of March 29th. This net worth evaluation does not reflect any other investments that Ms. Larson may own. Learn More about Sharon J. Larson's net worth.

How do I contact Sharon J. Larson?

The corporate mailing address for Ms. Larson and other Heska executives is 3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO, 80538. Heska can also be reached via phone at (970) 493-7272 and via email at [email protected]. Learn More on Sharon J. Larson's contact information.

Has Sharon J. Larson been buying or selling shares of Heska?

Sharon J. Larson has not been actively trading shares of Heska during the last quarter. Most recently, Sharon J. Larson sold 2,000 shares of the business's stock in a transaction on Tuesday, August 17th. The shares were sold at an average price of $266.83, for a transaction totalling $533,660.00. Following the completion of the sale, the director now directly owns 9,501 shares of the company's stock, valued at $2,535,151.83. Learn More on Sharon J. Larson's trading history.

Who are Heska's active insiders?

Heska's insider roster includes Catherine Grassman (CFO), Sharon Larson (Director), Kevin Wilson (CEO), and Nancy Wisnewski (COO). Learn More on Heska's active insiders.

Sharon J. Larson Insider Trading History at Heska

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/17/2021Sell2,000$266.83$533,660.009,501View SEC Filing Icon  
5/24/2021Sell3,000$205.00$615,000.0010,501View SEC Filing Icon  
5/4/2017Buy1,000$90.00$90,000.003,294View SEC Filing Icon  
See Full Table

Sharon J. Larson Buying and Selling Activity at Heska

This chart shows Sharon J Larson's buying and selling at Heska by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Heska Company Overview

Heska logo
Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell, platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was incorporated in 1988 and is based in Loveland, Colorado.
Read More

Today's Range

Now: $119.99
Low: $119.99
High: $119.99

50 Day Range

MA: $119.09
Low: $115.55
High: $119.99

2 Week Range

Now: $119.99
Low: $57.83
High: $120.03

Volume

N/A

Average Volume

241,932 shs

Market Capitalization

$1.31 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.58